Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.Circulation|May 2, 2024
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial HypertensionHaiyang Tang, Akash Gupta, Seth A Morrisroe, et al.Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.Nature Communications|October 9, 2024
Rare variant contribution to the heritability of coronary artery diseaseGhislain Rocheleau, Shoa L Clarke, Gaëlle Auguste, et al.Journal of the American Heart Association|February 14, 2025
Unveiling the Genetic Landscape of Coronary Artery Disease Through Common and Rare Structural VariantsKruthika R Iyer, Shoa L Clarke, Rodrigo Guarischi-Sousa, et al.JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.The New England Journal of Medicine|November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease, Nathan O Stitziel, Hong-Hee Won, et al.Nature|October 19, 2022
Semi-automated assembly of high-quality diploid human reference genomesErich D Jarvis, Giulio Formenti, Arang Rhie, et al.JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.The New England Journal of Medicine|June 19, 2014
Loss-of-function mutations in APOC3, triglycerides, and coronary disease, Jacy Crosby, Gina M Peloso, et al.Pageof 18